aBravo is a novel Aedes aegypti antiviral protein that interacts with, but acts independently of, the exogenous siRNA pathway effector Dicer 2

Varjak, M. , Rommel, G., Schnettler, E. and Kohl, A. (2020) aBravo is a novel Aedes aegypti antiviral protein that interacts with, but acts independently of, the exogenous siRNA pathway effector Dicer 2. [Data Collection]

Collection description

These datasets contain luciferase data contained in the paper.

College / School: College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Date Deposited: 09 Jul 2020 08:41
Funder's Name: Medical Research Council, European Commission (EC), British Council (UK) (BRCOU-UK)
URI: http://researchdata.gla.ac.uk/id/eprint/1010

Available Files

Data

Read me

Repository Staff Only: Update this record

Varjak, M. , Rommel, G., Schnettler, E. and Kohl, A. (2020); aBravo is a novel Aedes aegypti antiviral protein that interacts with, but acts independently of, the exogenous siRNA pathway effector Dicer 2

University of Glasgow

DOI: 10.5525/gla.researchdata.1010

Retrieved: 2020-09-28

Downloads

Downloads per month over past year